Literature DB >> 18566249

Censoring of autoreactive B cell development by the pre-B cell receptor.

Rebecca A Keenan1, Alessandra De Riva, Björn Corleis, Lucy Hepburn, Steve Licence, Thomas H Winkler, Inga-Lill Mårtensson.   

Abstract

Antibody diversity occurs randomly as B cells recombine their immunoglobulin (Ig) heavy- and light-chain genes during development. This process inevitably generates reactivity against self structures, and several mechanisms prevent the development of autoreactive B cells. We report here a role for the pre-B cell receptor, composed of Ig heavy and surrogate light chains, in the negative selection of cells expressing Ig heavy chains with the potential to generate autoantibodies. Surrogate light-chain-deficient (SLC-/-) mice harbored elevated levels of antinuclear antibodies (ANAs) in their serum and showed evidence of escape of pre-B cells expressing prototypic autoantibody heavy chains from negative selection, leading to mature autoantibody secreting CD21-CD23- B cells in the periphery. Thus, the pre-B cell receptor appears to censor the development of certain autoantibody-secreting cells and may represent an important factor in multifactorial autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566249     DOI: 10.1126/science.1157533

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  51 in total

1.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

2.  Multistoried roles for B lymphocytes in autoimmunity.

Authors:  Masaki Hikada; Moncef Zouali
Journal:  Nat Immunol       Date:  2010-12       Impact factor: 25.606

Review 3.  Impaired B lymphopoiesis in old age: a role for inflammatory B cells?

Authors:  Richard L Riley
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 4.  Inflammatory immune cells may impair the preBCR checkpoint, reduce new B cell production, and alter the antibody repertoire in old age.

Authors:  Richard L Riley; Kelly Khomtchouk; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2018-02-07       Impact factor: 4.032

5.  Efficient generation of B lymphocytes by recognition of self-antigens.

Authors:  Cathrin Eschbach; Martina P Bach; Ingrid Fidler; Roberta Pelanda; Fabian Köhler; Klaus Rajewsky; Hassan Jumaa
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

6.  A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice.

Authors:  Yi Hao; Patrick O'Neill; Martin S Naradikian; Jean L Scholz; Michael P Cancro
Journal:  Blood       Date:  2011-05-11       Impact factor: 22.113

Review 7.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

8.  Absence of surrogate light chain results in spontaneous autoreactive germinal centres expanding V(H)81X-expressing B cells.

Authors:  Ola Grimsholm; Weicheng Ren; Angelina I Bernardi; Haixia Chen; Giljun Park; Alessandro Camponeschi; Dongfeng Chen; Berglind Bergmann; Nina Höök; Sofia Andersson; Anneli Strömberg; Inger Gjertsson; Susanna Cardell; Ulf Yrlid; Alessandra De Riva; Inga-Lill Mårtensson
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

Review 9.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

10.  Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome.

Authors:  Barbara Cassani; Pietro Luigi Poliani; Veronica Marrella; Francesca Schena; Aisha V Sauer; Maria Ravanini; Dario Strina; Christian E Busse; Stephan Regenass; Hedda Wardemann; Alberto Martini; Fabio Facchetti; Mirjam van der Burg; Antonius G Rolink; Paolo Vezzoni; Fabio Grassi; Elisabetta Traggiai; Anna Villa
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.